Institute for Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Sell
2,709
-14
-0.5% -$5.19K 0.09% 195
2026
Q1
$797K Sell
2,723
-100
-4% -$32.9K 0.08% 236
2025
Q4
$990K Sell
2,823
-8
-0.3% -$2.7K 0.1% 192
2025
Q3
$915K Sell
2,831
-24
-0.8% -$7.46K 0.1% 214
2025
Q2
$1.11M Hold
2,855
0.12% 173
2025
Q1
$1.24M Sell
2,855
-11
-0.4% -$4.42K 0.16% 141
2024
Q4
$1.06M Sell
2,866
-130
-4% -$54.4K 0.13% 164
2024
Q3
$1.56M Sell
2,996
-33
-1% -$17.6K 0.2% 115
2024
Q2
$1.64M Sell
3,029
-3
-0.1% -$1.59K 0.22% 105
2024
Q1
$1.57M Hold
3,032
0.2% 109
2023
Q4
$1.43M Buy
3,032
+53
+2% +$24.5K 0.23% 106
2023
Q3
$1.3M Sell
2,979
-3
-0.1% -$1.36K 0.23% 105
2023
Q2
$1.32M Buy
2,982
+56
+2% +$25.8K 0.22% 112
2023
Q1
$1.35M Sell
2,926
-20
-0.7% -$9.52K 0.26% 101
2022
Q4
$1.51M Sell
2,946
-71
-2% -$36K 0.32% 82
2022
Q3
$1.37M Sell
3,017
-74
-2% -$35.4K 0.31% 89
2022
Q2
$1.49M Hold
3,091
0.29% 86
2022
Q1
$1.52M Sell
3,091
-5
-0.2% -$2.29K 0.25% 105
2021
Q4
$1.44M Hold
3,096
0.23% 112
2021
Q3
$1.15M Hold
3,096
0.2% 125
2021
Q2
$1.18M Hold
3,096
0.21% 120
2021
Q1
$1.11M Sell
3,096
-17
-0.5% -$5.47K 0.21% 125
2020
Q4
$1M Sell
3,113
-13
-0.4% -$3.99K 0.2% 128
2020
Q3
$840K Sell
3,126
-132
-4% -$35.5K 0.19% 135
2020
Q2
$857K Buy
3,258
+121
+4% +$32.3K 0.21% 128
2020
Q1
$712K Sell
3,137
-20
-0.6% -$5.45K 0.22% 130
2019
Q4
$954K Buy
3,157
+321
+11% +$88.3K 0.22% 128
2019
Q3
$681K Hold
2,836
0.17% 177
2019
Q2
$800K Sell
2,836
-54
-2% -$14.8K 0.18% 173
2019
Q1
$829K Hold
2,890
0.18% 155
2018
Q4
$759K Buy
+2,890
New +$795K 0.31% 101
2018
Q1
Sell
-2,908
Closed -$656K 295
2017
Q4
$656K Buy
+2,908
New +$619K 0.15% 188
2017
Q3
Sell
-2,952
Closed -$556K 285
2017
Q2
$556K Buy
+2,952
New +$530K 0.15% 206

Other funds holding ELV

Institute for Wealth Management's ELV Position: Q2 2026 in Review

Institute for Wealth Management reduced its Elevance Health (ELV) stake by 0.51% in Q2 2026, selling an estimated $5.19K and leaving 2,709 shares worth $1.05M. The position accounts for 0.09% of the portfolio, ranked #195.

Institute for Wealth Management first reported a position in ELV in Q2 2017 and has held it in 33 quarters since. The position peaked at $1.64M in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Institute for Wealth Management held 2,709 shares of Elevance Health worth $1.05M as of Q2 2026.
  • Institute for Wealth Management sold 14 Elevance Health shares in Q2 2026, an estimated $5.19K.
  • Elevance Health made up 0.09% of Institute for Wealth Management's portfolio in Q2 2026, its #195 holding.
  • Institute for Wealth Management first reported a position in Elevance Health in Q2 2017 and has held it in 33 quarters since.
  • Institute for Wealth Management's Elevance Health position peaked at $1.64M in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Institute for Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.